Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19

Dataset

Description

Journal of Biomolecular Structure and Dynamics, 1-11
Date made available1 Jan 2020
PublisherTaylor & Francis

Cite this